After almost a year of behind-the-scenes work, billionaire hedge-fund manager John Paulson has formed a coalition with 15 other investors aimed at curbing years of what his fund...
Keep Reading →
September 21 - Hedge Funds, Insider Trading - Comments
September has seen a huge uptick in terms of insider buying activity, with the five most active days for insider purchasing this year all having fallen within the past two weeks...
Keep Reading →
September 18 - Insider Trading, News - Comments
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings.
Keep Reading →
April 3 - Market Movers, News - Comments
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share...
Keep Reading →
September 1 - Lists, News - Comments
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) just put out data from its lead pivotal, and the company is up close to 50% on the numbers.
Keep Reading →
August 30 - News, Stock Analysis - Comments
Rigel Pharmaceuticals, Inc.
Keep Reading →
August 23 - News, Stock Analysis - Comments
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Keep Reading →
May 31 - Hedge Funds, News - Comments
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Keep Reading →
December 30 - Hedge Funds, News - Comments
Big Pharma gets plenty of hype.
Keep Reading →
September 17 - News - Comments
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Keep Reading →
September 17 - News - Comments
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 17 - News - Comments
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
Keep Reading →
September 13 - News - Comments
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Keep Reading →
September 4 - News - Comments
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 3 - News - Comments
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
September 1 - News - Comments
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Keep Reading →
August 30 - News - Comments
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Keep Reading →
August 26 - News - Comments
At the moment, there are plenty of metrics shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading activity.
Keep Reading →
June 17 - News - Comments
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Keep Reading →
June 12 - News - Comments
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 16 hedge funds' portfolio at the end of March.
Keep Reading →
June 12 - News - Comments
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
June 10 - News - Comments
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Keep Reading →
June 10 - News - Comments
According to most shareholders, hedge funds are seen as unimportant, outdated investment vehicles of years past.
Keep Reading →
June 4 - News - Comments
Leading health-care stocks have had a good start to the year, but all's not healthy in the world of medicine.
Keep Reading →
May 4 - News - Comments
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage drug development company ...
Keep Reading →
April 8 - News - Comments
With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 7 - News - Comments
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode.
Keep Reading →
April 6 - News - Comments
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 5 - News - Comments
